(Press-News.org) CAMBRIDGE, MA -- Although malaria has been eradicated in many countries, including the United States, it still infects more than 200 million people worldwide, killing nearly a million every year. In regions where malaria is endemic, people rely on preventive measures such as mosquito netting and insecticides. Existing drugs can help, but the malaria parasite is becoming resistant to many of them.
Scientists working to develop new drugs and vaccines hope to target the parasite in the earliest stages of an infection, when it quietly reproduces itself in the human liver.
In a major step toward that goal, a team led by MIT researchers has now developed a way to grow liver tissue that can support the liver stage of the life cycle of the two most common species of malaria, Plasmodium falciparum and Plasmodium vivax. This system could be used to test drugs and vaccines against both species, says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science at MIT.
Bhatia is the senior author of a paper describing the liver-tissue system in the July 17 issue of the journal Cell Host & Microbe. The paper's lead author is Sandra March, a research scientist in Bhatia's lab, and scientists from the Broad Institute, Sanaria Inc. and the University of Lisbon also contributed to the research.
Reproducing infection
The malaria life cycle has several stages. Once the parasite infects a human victim, through a mosquito bite, it takes up residence in the liver. The parasite spends about a week in the liver, producing tens of thousands of copies that eventually burst free to infect blood cells. After this initial infection, P. vivax can lurk for weeks, months or even years, reactivating to cause another malaria bout.
So far, researchers have been able to grow P. falciparum in human blood and, to a certain extent, in its liver stages, but they have not been able to reliably grow P. vivax in either stage. P. falciparum has the highest malaria mortality rate, but P. vivax can cause debilitating, long-term infections. To eradicate malaria, drugs and vaccines that target both species will probably be needed, Bhatia says.
Bhatia — who is also a senior associate member of the Broad Institute and a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science — has previously created micropatterned surfaces on which liver tissue can be grown, surrounded by supportive cells. These engineered cells survive for up to six weeks and mimic most of the functions of liver cells in the body, including drug metabolism and production of liver proteins.
Using unique, frozen samples of P. falciparum obtained in collaboration with Stephen L. Hoffman and his team at Sanaria, the researchers infected healthy liver cells and observed the development of liver-stage parasites using an automated imaging system designed in collaboration with Anne Carpenter's group at the Broad Institute. This system allows them to quickly evaluate not only how much infection has occurred, but also the effects of potential drugs. They can also measure how weakened forms of the parasites, which could be used as vaccines, perform in the liver.
To test the system's usefulness, the researchers studied a P. falciparum vaccine that is now in clinical trials. For a weakened, or attenuated, parasite to succeed as a vaccine, it must infect the liver and progress enough to raise an immune response, but then arrest and not reach the blood stage. The researchers showed that the vaccine now in trials does follow that trajectory.
The new system could also be used for larger-scale drug studies than previously possible, Bhatia says. Researchers now use liver cancer cells grown in the lab to study P. falciparum infection, but those cells have deficient drug metabolism and keep growing instead of providing a quiet home for the parasite to persist.
Seeking P. vivax
Obtaining enough P. vivax samples to test the system took several years, but the team eventually acquired samples, flown in from Thailand, India and South America. Using these samples, they were able to grow P. vivax in liver tissue and show that it produces small persistent parasites that appear to be dormant forms called hypnozoites.
"We don't want to call them hypnozoites yet, because nobody has a gold-standard marker for them, but we have persistent small forms that live for three weeks. So we are optimistic and doing more to wake them up again. Reactivation would be the ultimate confirmation," Bhatia says.
The researchers are now working on confirming that the P. vivax they grew in the liver tissue really did create hypnozoites. Once this is confirmed, they plan to start testing some candidate drugs, now in development, against P. vivax.
###
The research was funded by the Bill and Melinda Gates Foundation, Medicines for Malaria Venture, the National Institute of Allergy and Infectious Disease, the National Institutes of Health and the Howard Hughes Medical Institute.
Written by Anne Trafton, MIT News Office
New way to target an old foe: Malaria
Engineered liver tissue developed at MIT could help scientists test new drugs and vaccines
2013-07-17
ELSE PRESS RELEASES FROM THIS DATE:
Accurate prognosis for epilepsy patients
2013-07-17
Scientists at Bonn University Hospital and at the Max Planck Institute for neurological research in Cologne have developed a method with which the chances of success of a surgical procedure for temporal lobe epilepsy can be accurately predicted. The rate of accurate predictions is more than 90%. The results are now being presented in the scientific journal "NeuroImage:Clinical."
When many nerve cells simultaneously fire in the brain, an epileptic seizure results. The most frequent form is temporal lobe epilepsy. It originates in one of the two temporal lobes which contain, ...
Injectable 'smart sponge' holds promise for controlled drug delivery
2013-07-17
Researchers have developed a drug delivery technique for diabetes treatment in which a sponge-like material surrounds an insulin core. The sponge expands and contracts in response to blood sugar levels to release insulin as needed. The technique could also be used for targeted drug delivery to cancer cells.
"We wanted to mimic the function of health beta-cells, which produce insulin and control its release in a healthy body," says Dr. Zhen Gu, lead author of a paper describing the work and an assistant professor in the joint biomedical engineering program at North Carolina ...
Information in brain cells' electrical activity combines memory, environment, and state of mind
2013-07-17
The information carried by the electrical activity of neurons is a mixture of stored memories, environmental circumstances, and current state of mind, scientists have found in a study of laboratory rats. The findings, which appear in the journal PLoS Biology, offer new insights into the neurobiological processes that give rise to knowledge and memory recall.
The study was conducted by Eduard Kelemen, a former graduate student and post-doctoral associate at the State University of New York (SUNY) Downstate Medical Center, and André Fenton, a professor at New York University's ...
Outgoing people lead happier lives
2013-07-17
Research from the University of Southampton has shown that young adults, who are more outgoing or more emotionally stable, are happier in later life than their more introverted or less emotionally stable peers.
In the study, published in the Journal of Research in Personality, Dr Catharine Gale from the Medical Research Council's Lifecourse Epidemiology Unit, University of Southampton and a team from the University of Edinburgh and University College London, examined the effects of neuroticism and extraversion at ages 16 and 26 years on mental wellbeing and life satisfaction ...
Birds and humans have similar brain wiring
2013-07-17
A researcher from Imperial College London and his colleagues have developed for the first time a map of a typical bird brain, showing how different regions are connected together to process information. By comparing it to brain diagrams for different mammals such as humans, the team discovered that areas important for high-level cognition such as long-term memory and problem solving are wired up to other regions of the brain in a similar way. This is despite the fact that both mammal and bird brains have been evolving down separate paths over hundreds of millions of years.
The ...
Danish survey evaluates the content of chemical contaminants in food
2013-07-17
The National Food Institute, Technical University of Denmark has evaluated the content of chemical contaminants in food in the period 2004-2011 at the request of the Danish Veterinary and Food Administration.
The content of chemical contaminants is evaluated in relation to which specific foods Danes eat, and how much. The latest monitoring report includes even more compounds than the one from 2003.
"Monitoring of unwanted compounds is performed to ensure that the food eaten by the Danish people does not contain too many harmful compounds. In general, Danes should not ...
Deciphering butterflies' designer colors: Findings could inspire new hue-changing materials
2013-07-17
WASHINGTON, July 17—Butterfly wings can do remarkable things with light, and humans are still trying to learn from them. Physicists have now uncovered how subtle differences in the tiny crystals of butterfly wings create stunningly varied patterns of color even among closely related species. The discovery, reported today in the Optical Society's (OSA) open-access journal Optical Materials Express, could lead to new coatings for manufactured materials that could change color by design, if researchers can figure out how to replicate the wings' light-manipulating properties.
"It ...
The key to ion beams' polarizability
2013-07-17
Polarisability determines the force with which an inhomogeneous external electric field acts on the ions of an ion beam. However, it can be quite tricky to obtain accurate values for this force. Now, two German theoretical chemists, Volker Koch from Bielefeld University and Dirk Andrae from the Free University Berlin, have devised formulas providing the polarisability of atomic ions as a function of their total charge number. Their findings, about to be published in EPJ D, have implications for many applications, ranging from the use of ion beams for research purposes or ...
Monkey nation: Study confirms wealth of primates in Tanzania
2013-07-17
NEW YORK (July 17, 2013) — A five-year study by the Wildlife Conservation Society gives new hope to some of the world's most endangered primates by establishing a roadmap to protect all 27 species in Tanzania – the most primate-diverse country in mainland Africa.
The study combines Tanzania's first-ever inventory of all primate species and their habitats with IUCN Red List criteria and other factors such as threats and rarity, ranking all 27 species from most vulnerable to least vulnerable. The authors then identify a network of "Priority Primate Areas" for conservation. ...
A new Anagnorisma moth species from the beautiful Binaloud Mountain Iran
2013-07-17
Researchers described a new species of Noctuidae moth from Iran which is the fifth described species of the genus Anagnorisma. The new species A. chamrani has its name in honour of Dr. Mostafa Chamran (1932–1981), an Iranian scientist and defence minister. The study was published in the open access journal Zookeys.
During an expedition at high altitude of above 2500 m of north-eastern Iran on a cold night in late summer 2012, a couple of undescribed specimens of Anagnorisma moths were collected. The specimens had been attracted to an ultraviolet light trap on the Binaloud ...
LAST 30 PRESS RELEASES:
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project
[Press-News.org] New way to target an old foe: MalariaEngineered liver tissue developed at MIT could help scientists test new drugs and vaccines